Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers

AIMS: A better understanding of the expression of cancer/testis antigens (CTAs) in breast cancer might enable the identification of new immunotherapy options, especially for triple‐negative (TN) tumours, which lack expression of the conventional therapeutic targets oestrogen receptor, progesterone r...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghavendra, Ashwini, Kalita‐de Croft, Priyakshi, Vargas, Ana C, Smart, Chanel E, Simpson, Peter T, Saunus, Jodi M, Lakhani, Sunil R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635746/
https://www.ncbi.nlm.nih.gov/pubmed/29465777
http://dx.doi.org/10.1111/his.13498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635746/
https://www.ncbi.nlm.nih.gov/pubmed/29465777
http://dx.doi.org/10.1111/his.13498

Ejemplares similares